Phase 1 Study of MKC-1 in Patients With Advanced Cancer

Clinical trial NCT00656461 · COMPLETED

Trial details

NCT number: NCT00656461
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-03-01
Primary completion: 2009-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.